A prospective case–control study involving 300 NAFLD patients and 300 healthy controls indicated that APOC3 rs2854116 genetic variations involved in the susceptibility to develop NAFLD, IR, hypertriglyceridemia, and low HDL in the Southern Chinese Han population [39]. The gene discussed is APOC3; the disease is metabolic dysfunction-associated steatotic liver disease.